very high risk
Showing 1 - 25 of >10,000
MDS Trial (Decitabine/Cedazuridine, Magrolimab)
Not yet recruiting
- Myelodysplastic Syndromes
- (no location specified)
Apr 18, 2023
Atherosclerotic Cardiovascular Disease Trial (Atozet 10/40 mg or 10/80 mg, Lipitor 40 mg or 80 mg)
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- Atozet 10/40 mg or 10/80 mg
- Lipitor 40 mg or 80 mg
- (no location specified)
Mar 8, 2023
Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)
Not yet recruiting
- Prostate Cancer
- Newly-Diagnosed Prostate Cancer
- (no location specified)
Nov 3, 2023
Dyslipidemia in Patients at High Risk and Very High Risk of
Recruiting
- Secondary Prevention
- +2 more
- application
-
Leon, Guanajuato, MexicoUmae Cmn T1
Sep 13, 2022
Acute Cholecystitis Trial in Hong Kong (Endoscopic ultrasound-guided gallbladder drainage, Antibiotics first)
Recruiting
- Acute Cholecystitis
- Endoscopic ultrasound-guided gallbladder drainage
- Antibiotics first
-
Hong Kong, Hong KongThe Chinese Universtiy of Hong Kong
May 29, 2023
Myelodysplastic Syndrome (MDS) Trial in Worldwide (sabatolimab, azacitidine, venetoclax)
Active, not recruiting
- Myelodysplastic Syndrome (MDS)
- sabatolimab
- +2 more
-
Brasschaat, Belgium
- +9 more
Jan 19, 2023
Prostate Cancer Trial in Beijing (Darolutamide+ADT)
Not yet recruiting
- Prostate Cancer
-
Beijing, ChinaPeking University First Hospital
Sep 1, 2023
Atherosclerotic Cardiovascular Disease, STEMI, Non STEMI Trial in Netherlands
Enrolling by invitation
- Atherosclerotic Cardiovascular Disease
- +2 more
-
Alkmaar, Netherlands
- +12 more
Dec 12, 2022
Acute Lymphoid Leukemia Trial in Philadelphia (huCART19)
Recruiting
- Acute Lymphoid Leukemia
- huCART19
-
Philadelphia, PennsylvaniaChildren's Hospital of Pennsylvania
Jul 21, 2022
Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)
Not yet recruiting
- Acute Myeloid Leukemia
- High-Risk and Very High-Risk Myelodysplastic Syndromes
- (no location specified)
Jul 25, 2023
Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel Trial in Nanjing (Docetaxel injection, Triptorelin Pamoate for
Active, not recruiting
- Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
- Docetaxel injection
- +2 more
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Dec 24, 2022
Locally Advanced and Metastatic Prostate Cancer Trial in Vienna (Radical prostatectomy)
Recruiting
- Locally Advanced and Metastatic Prostate Cancer
- Radical prostatectomy
-
Vienna, AustriaMedical University of Vienna
Apr 4, 2022
Locally Advanced Rectal Cancer, Total Neoadjuvant Treatment, Anti-PD-1 Trial in Changchun (nCRT ? (CapeOX+Sintilimab)×6 ?
Not yet recruiting
- Locally Advanced Rectal Cancer
- +2 more
- nCRT → (CapeOX+Sintilimab)×6 → Surgery/W&W
-
Changchun, Ji Lin, ChinaFirst Hospital of Jilin University
Aug 11, 2023
Hodgkin's Lymphoma Trial in Milan (histone deacetylase inhibitor (ITF2357))
Terminated
- Hodgkin's Lymphoma
- histone deacetylase inhibitor (ITF2357)
-
Milan, ItalyIstituto Nazionale per lo studio e la cura dei Tumori
Jan 18, 2022
AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)
Recruiting
- AML
- +3 more
- Azacitidine
- all trans retinoic acid
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Dec 27, 2021
HIV/AIDS Trial in Entebbe (POPPi behavioral intervention)
Completed
- HIV/AIDS
- POPPi behavioral intervention
-
Entebbe, UgandaUganda Virus Research Institute
Mar 21, 2022
Prostate Cancer Trial in Nanning (Darolutamide 300 mg, Androgen deprivation therapy)
Not yet recruiting
- Prostate Cancer
- Darolutamide 300 mg
- Androgen deprivation therapy
-
Nanning, Jiangsu, ChinaHongqian Guo
Feb 19, 2022
Breast Cancer, Malignant Tumor of Breast Trial in Cleveland (Immediate Breast Reconstruction, Delayed Breast Reconstruction,
Withdrawn
- Breast Cancer
- Malignant Neoplasm of Breast
- Immediate Breast Reconstruction
- +2 more
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
May 16, 2022
Cardiovascular Diseases, Uric Acid Trial (Allopurinol 200 mg, Optional intervention)
Not yet recruiting
- Cardiovascular Diseases
- Uric Acid
- Allopurinol 200 mg
- Optional intervention
- (no location specified)
Jul 5, 2023
Acute Myeloid Leukemia, Adult, MDS Trial in Marseille, Paris, Pierre-Bénite (ABD-3001)
Active, not recruiting
- Acute Myeloid Leukemia, Adult
- Myelodysplastic Syndromes
-
Marseille, France
- +2 more
Jan 19, 2023
High Risk Hematological Malignancy, Cord Blood Transplant Trial in Seattle (ECT-001-CB (UM171-Expanded Cord Blood Transplant))
Recruiting
- High Risk Hematological Malignancy
- Cord Blood Transplant
- ECT-001-CB (UM171-Expanded Cord Blood Transplant)
-
Seattle, WashingtonFred Hutchinson / University of Washington Cancer Consortium
Jan 12, 2022
Bronchopulmonary Dysplasia, Child Development, Neonatal and Perinatal Conditions Trial in Québec (High-dose DHA, Control)
Not yet recruiting
- Bronchopulmonary Dysplasia
- +2 more
- High-dose DHA
- Control
-
Québec, Quebec, CanadaCHU de Québec-Université Laval
Jun 20, 2023